| | 
Part, Chapter, Paragraph
1 I, 2. 5. 0(3) | EUROSTAT Newsrelease 180§/2008, 16 December 2008, accessed
2 I, 2. 10. 4(9) | Departement of Healthh – 16 February 2007~
3 I, 2. 10. 4(12)| Departament of Health – 16 Febrauary 2007~
4 I, 2. 10. 4(19)| Depertament of health – 16 February 2007~
5 I, 2. 10. 4(22)| UK Department of Health – 16 February 2007~
6 I, 3. 1 | had the lowest. As many as 16 out of the 27 EU Member
7 I, 3. 4 | MIGRATION PERSPECTIVES No. 16, October 2004. Available
8 II, 4. 3 | Population and Development Review 16(3): 403-432.~ ~Robine, J.-
9 II, 5. 2. 3 | 555 in Latvia; in women 16 per 100.000 in France and
10 II, 5. 3. 9 | Working Group Study. JCO 23(16): 3742-3751.~ ~Hakama M,
11 II, 5. 4. 2 | tested in last 12 months~16~Percent of diabetic subjects
12 II, 5. 4. 3 | published by EUCID vary from 16% (Ireland) to 84% (Scotland),
13 II, 5. 5. 1 | J Psychiatry 159(6):909-16.~ ~Ormel J, Petukhova M,
14 II, 5. 5. 3 | adolescents between 13 and 16 years of age (3000 adolescents).
15 II, 5. 5. 3 | Europe by nutrition in 13-16 years adolescents across
16 II, 5. 5. 3 | 1.0%.~Worldwide, between 16 and 42 per 100 000 population
17 II, 5. 5. 3 | Germany, 23% in France, 16% in Czech Republic, and
18 II, 5. 5. 3 | than the world average (16%). However, it may also
19 II, 5. 5. 3 | help. European Psychiatry 16:207–214.~Palmer BA, Pankratz
20 II, 5. 5. 3 | followed by trauma (2-16%) and neoplasms (6-10%).~
21 II, 5. 5. 3 | localization-related epilepsy in 16% (8.8 per 100,000 per year),
22 II, 5. 5. 3 | GP/MF~Incident cohort~149~16.1~9.3~Loiseau et al., 1999~
23 II, 5. 5. 3 | comparing individuals aged 16 to 64 to those aged 65 or
24 II, 5. 5. 3 | than 10 in patients aged 16-64 and greater than 5 in
25 II, 5. 5. 3 | was found in patients aged 16 to 64, organic psychoses,
26 II, 5. 5. 3 | below average level and 16% were seriously behind (
27 II, 5. 5. 3 | compulsory notification. Med Law 16:253-267.~Blom S, Heijbel
28 II, 5. 5. 3 | prevention. Epilepsy Res 60:1-16.~Vaa T (2005): Impairments,
29 II, 5. 5. 3 | Health Policy and Planning 16;326-331.~Freal JE, Kraft
30 II, 5. 5. 3 | Bulgaria. Neuroepidemiology 16:304-307~Miller D, Noseworthy
31 II, 5. 5. 3 | disease. Pharmacoeconomics 16(1):59-69.~Lindgren P, von
32 II, 5. 6. 3 | sickness in men and women from 16 to 74 years of age in the
33 II, 5. 6. 3 | prevalence in women aged 16-74.~ ~The incidence and
34 II, 5. 6. 6 | Technol Assess Health Care 16(4):1193-200~Juni P, Dieppe
35 II, 5. 6. 6 | in Europe. Osteoporos Int 16(3):229-38~Kaukonen JP, Karaharju
36 II, 5. 6. 6 | Pract Res Clin Rheumatol 16:741-760~Picavet HS, Hazes
37 II, 5. 7. 2 | the period 1996-2000 from 16 renal registries in 9 EU-15
38 II, 5. 7. 3 | in 1978. By comparison, 16 cases of ESRD had developed
39 II, 5. 7. 3 | from 14.5% (NHANES III) to 16.8% (NHANES IV) (Tonelli
40 II, 5. 7. 7 | Am Soc Nephrol 2005 Jan;16(1):180-8.~de Zeeuw D, Hillege
41 II, 5. 7. 7 | Am Soc Nephrol 2005 Jul;16(7):2134-40.~Levey AS, Bosch
42 II, 5. 7. 7 | Ann Intern Med 1999 Mar 16;130(6):461-70.~Levin A (
43 II, 5. 7. 7 | Nephrol Dial Transplant 2001;16 Suppl 7:57-60~Lin J, Knight
44 II, 5. 8. 3 | and 1993 in 35 centres of 16 countries (13 EU and EFTA
45 II, 5. 8. 3 | pneumonia (relative risk (RR) = 16.0), osteoporosis (RR = 3.
46 II, 5. 8. 3 | FFMI) <15 (females) or <16 (males) kg/m2) in a large
47 II, 5. 8. 5 | in patients with AO was 16.3%, whereas it was 12.0%
48 II, 5. 8. 7 | publication, accessed on 16 April 2007)~ ~Gorecka D,
49 II, 5. 8. 7 | J Nurs Manag. 2008 Mar; 16(2): 173-80~ ~Halbert RJ,
50 II, 5. 8. 7 | Eur J Public Health 2006; 16: 101-105.~ ~Murray CJ, Lopez
51 II, 5. 9. FB | from 3.7% in Greece, to 16% in Finland and up to 32%
52 II, 5. 9. 3 | duration of the disease (5.6 vs 16.1 years, P 001) than patients
53 II, 5. 9. 3 | of 6-7 years of age and 16.9% in children of 13.14
54 II, 5. 9. 3 | in all three disorders, 16 recorded increases, and
55 II, 5. 9. 4 | median between centre 21.7%, 16.9% and 8.8%, respectively).
56 II, 5. 11. 3 | Danish school children (12-16 yrs)~Lifetime prevalence=
57 II, 5. 11. 3 | Danish school children (12-16 yrs)~Prevalence=15%~Mortz
58 II, 5. 11. 3 | Swedish school children (16-19 yrs)~Point prevalence=
59 II, 5. 11. 3 | school children aged 12-16 yrs~Point prevalence=3%,
60 II, 5. 11. 3 | Europe Eur J Dermatol 2006;16:212-218~ ~ ~Table 5.11.2.
61 II, 5. 11. 3 | topical corticosteroid) and 16% were moderate or severe (
62 II, 5. 11. 7 | Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
63 II, 5. 12. 1 | 30-40/100,000 men and 10-16/100,000 women) in Europe
64 II, 5. 14. 3 | countries (12.8% in Italy, 16.3% in France, 58% in United
65 II, 5. 15. 4 | Parliament and of the Council of 16 December 1999 on orphan
66 II, 5. 15. 6 | Orphan Drugs. Published 16/11/04. Available at:~htt / (
67 II, 6. 3. 1 | Netherlands (population of 16 million) in 2004 the cost
68 II, 6. 3. 6 | countries. The Czech Republic (16.72 per 100 000) followed
69 II, 6. 3. 6 | 000 cases were reported by 16 countries, with Ireland (
70 II, 6. 4. 4 | The ECDC has a budget of € 16 million with 100 staff.
71 II, 7. 3. 5 | suicide attempts (Figure 7.16).~ ~Figure 7.15.b. Suicide
72 II, 7. 3. 5 | and self-harm.~ ~Figure 7.16. Hospital deaths and discharges
73 II, 8. 1. 2 | results refer to persons aged 16-64 years, living in private
74 II, 8. 1. 3 | is estimated that about 16% of men and women aged 16-
75 II, 8. 1. 3 | 16% of men and women aged 16-64 in the EU have a long
76 II, 8. 1. 3 | 10% of men and women aged 16-64.~ ~Table 8.1. Proportion
77 II, 8. 1. 3 | Proportion of people aged 16-64 with a long-standing
78 II, 8. 1. 3 | than 4% in the age group 16-24, 9% in the age group
79 II, 8. 1. 3 | frequent, in the age group 16-24 years compared with older
80 II, 8. 1. 3 | training among those aged 16-19 was 63% for persons with
81 II, 8. 1. 3 | people in the age group 16-64 were 28% among those
82 II, 8. 1. 3 | limitations. Among people aged 16-24 with considerable limitations,
83 II, 8. 1. 3 | proportion of men in working age (16-64 years) with income below
84 II, 8. 1. 3 | women of working age, about 16% of those with considerable
85 II, 8. 2. 3 | Arlinger, 2003) showed that 16.9% subjects showed no hearing
86 II, 9 | 2004). Data from ESPAD from 16 year olds shows a range
87 II, 9 | cannabis than girls: 22% and 16%, respectively, and have
88 II, 9. 1. 1 | meta-analyses. Am J Prev Med 1999;16(3):208-15.~Cleary-Goldman
89 II, 9. 1. 1 | Gynecol 1993;168(1 Pt 1):16-21.~De Galan-Roosen AE,
90 II, 9. 1. 1 | Paediatr Perinat Epidemiol 16(1):16-22.~ ~Langer B, Caneva
91 II, 9. 1. 1 | Perinat Epidemiol 16(1):16-22.~ ~Langer B, Caneva MP,
92 II, 9. 1. 1 | prematurely (<32 weeks) in 16 European centres: a database
93 II, 9. 2. 3 | high as 18.4% for Scotland, 16.8% for Wales, 15.3% for
94 II, 9. 2. 4 | 2004). Data from ESPAD from 16 year olds shows a range
95 II, 9. 2. 4 | cannabis than girls: 22% and 16%, respectively, and have
96 II, 9. 2. 7 | formation: evidence from 16 FFS countries. Demographic
97 II, 9. 3. 1 | increasing from 2.1 to 4.6 to 16.0 per 100 000 population
98 II, 9. 3. 1 | Organisation (WHO), and by 16% across the European Union
99 II, 9. 3. 2 | meta-analyses. Am J Prev Med 1999;16(3):208-15.~ ~Cleary-Goldman
100 II, 9. 3. 2 | Gynecol 1993;168(1 Pt 1):16-21.~ ~Cnattingius S (2004):
101 II, 9. 3. 2 | Paediatr Perinat Epidemiol 2002;16(1):16-22.~ ~Kramer MS, Seguin
102 II, 9. 3. 2 | Perinat Epidemiol 2002;16(1):16-22.~ ~Kramer MS, Seguin
103 II, 9. 3. 2 | prematurely (<32 weeks) in 16 European centres: a database
104 II, 9. 3. 3 | was found in the UK, at 16.2 (Bajos et al, 2003); the
105 II, 9. 3. 3 | intercourse before the age of 16 does not appear to have
106 II, 9. 3. 3 | campaigns. Eur J Public Health 16(5):498-504.~Thompson JC,
107 II, 9. 5. 3 | by a stranger after age 16~· 18.2% of women reported
108 II, 9. 5. 3 | by a stranger after age 16~Hungaryb ( 1999 data )~·
109 II, 9. 5. 3 | data )~· 2.2% of women over 16 reported being raped~· 9.
110 II, 9. 5. 3 | occasion since the age of 16~ a European Women’s Lobby,
111 II, 9. 5. 3 | of age. A survey among 15-16 year-olds found that 26%
112 II, 9. 5. 5 | the Council Conclusions of 16.12.2005 on the implementation
113 II, 9. 5. 6 | billion. Press release: 16.06.05. Available at:~htt p~(
114 II, 9. 5. 6 | against women in Europe. 16.10.2004. Available at:~htt 4 (
115 II, 9. 5. 6 | Available at: ( accessed 16.07.07)~ ~Klinge I, Bosch
116 II, 9. 5. 6 | Available at: (accessed 16.07.07)~ ~Paechter C (2003):
117 III, 10. 2. 1 | the adult population aged 16+) do not drink alcohol at
118 III, 10. 2. 1 | classified as heavy drinkers (16% of the adult population),
119 III, 10. 2. 1 | Nearly all (over 9 in 10) 15-16 year-old students have drunk
120 III, 10. 2. 1 | amount of alcohol drunk by 15-16 year olds on the last drinking
121 III, 10. 2. 1 | over 1 in 8 (13%) of 15-16 year old students have been
122 III, 10. 2. 1 | cause of child abuse in 16% of cases.~The risk of drinking
123 III, 10. 2. 1 | in 6 of all suicides)~- 16% of all child abuse / neglect~-
124 III, 10. 2. 1 | 000 for women (as well as 16,000 DALYs per million people
125 III, 10. 2. 1 | old or younger. Among 15-16 year olds, lifetime (i.e.
126 III, 10. 2. 1 | than for cannabis among 15-16 year olds. In most countries,
127 III, 10. 2. 1 | for the adult population (16-64 years old). In the medium
128 III, 10. 2. 1 | Survey~BNFCS2004~2004~1723~16-64~24-hour recall~2~General
129 III, 10. 2. 1 | Nutritional Status~ ~2004~853~16-64~24-hour recall~1~-~Croatia~
130 III, 10. 2. 1 | SISP04~2003 - 2004~1751~16-64~24-hour recall~2~General
131 III, 10. 2. 1 | adults~NORKOST~1997~2672~16-79~Food Frequency Questionnaire~ ~ ~
132 III, 10. 2. 1 | data from 75 surveys in 16 European countries(15 EU
133 III, 10. 2. 1 | Journal of Human Biology 16:670-678.~ ~Power C (1994):
134 III, 10. 2. 4 | reaction, Human Mutation, 16 (1): 77 – 85.~ ~Rothman
135 III, 10. 3. 2 | health problems. 14 of the 16 European companies that
136 III, 10. 3. 4 | Million US $ from floods and 16 598 Million US $ from storms.
137 III, 10. 4. 1 | meeting, Bonn, Germany 15-16 January 2004. Available
138 III, 10. 4. 2(28)| Directive 79/700/EEC (OJ L 187, 16.7.2002, p 30)~
139 III, 10. 4. 2 | pathogenic micro organisms (16%). A total of 2009 information
140 III, 10. 4. 2 | ECDC). These data covered 16 zoonotic diseases. Assisted
141 III, 10. 4. 2 | requirements were held in 16 “rounds” (Figure 10.4.2.
142 III, 10. 4. 2 | Directive N. 89/662/EEC (16)) and on products entering
143 III, 10. 4. 2 | genotoxic and carcinogenic. 16-18 November 2005. pp.286.~ ~
144 III, 10. 4. 5 | exports in GDP increased from 16%-31%, while the share of
145 III, 10. 4. 5 | waste entered into force on 16.07.1999 (European Commission,
146 III, 10. 4. 5 | in the Member States was 16.07.2001. The objective of
147 III, 10. 5. 1 | Finland), with an average of 16% (2001 data, EUROSTAT WHO
148 III, 10. 5. 1 | which resulted in over 16 700 cases of illness) were
149 III, 10. 5. 1 | Journal of Public Health, Vol. 16, No. 6, 583–591;~ ~Wargocki
150 III, 10. 5. 2 | higher for rural settings (16.4 deaths per 1.000 populations
151 III, 10. 5. 2 | FILE/rural.pdf (accessed on 16 January 2008) ~Campbell
152 III, 10. 5. 2 | Family Practice 2005, 6:16.~[http://www.biomedcentral.
153 III, 10. 5. 2 | biomedcentral.com/1471-2296/6/16] (accessed on 19 September
154 IV, 11. 5. 3 | technical guidelines. Figure 11.16 shows the biological tests
155 IV, 11. 5. 3 | characteristics.~ ~Figure 11.16. Biological tests in organ
156 IV, 11. 5. 3 | transplant~ ~As Figure 11.16 shows, there is consensus
157 IV, 11. 5. 6 | Ministers of Health (Paris, 16-17 November 1987) - Reports:~ –
158 IV, 11. 6. 4 | funding based on DRGs)~Poland~16 regional funds + 1 trade
159 IV, 11. 6. 5 | Euro Health 13(1): 13-16.~ ~Brook R, McGlynn E et
160 IV, 11. 6. 5 | Assessment in Health Care 16(4): 969-975.~ ~Eisenhardt
161 IV, 11. 6. 5 | Assessment in Health Care 16(4): 1050-60.~ ~Gemmill M,
162 IV, 11. 6. 5 | Assessment in Health Care 16: 210-27.~ ~Hills J (2000):
163 IV, 11. 6. 5 | of Public Health Medicine 16:321-30.~ ~Holland WW, Stewart
164 IV, 11. 6. 5 | for Quality in Health Care 16(S1): i45-i50.~ ~Marshall
165 IV, 11. 6. 5 | Health Planning Management 16: 229-41.~ ~Pauly M (1968): "
166 IV, 11. 6. 5 | Assessment in Health Care 16(4): 1061-76.~ ~Rizzo J,
167 IV, 12. 8 | number of fields. Article 16 of that Protocol deals with
168 IV, 12. 10 | people under the age of 16.~htt ~ ~Statutory Order
169 IV, 12. 10 | people under the age of 16.~htt 78~1990-: Week 40 campaigns.~
170 IV, 12. 10 | purchase tobacco rose from 16 to 18 years of age~ ~Public
171 IV, 12. 10 | from €3.67 billion to over €16 billion in 2008.~ ~Modernisation
172 IV, 12. 10 | compliance with the Article 16 of the WHO‘s Contract.~The
173 IV, 12. 10 | 58~o Presidential Degree 16/1996 “Minimum standards
174 IV, 12. 10 | between State and Regions (16.03.2006): work activities
175 IV, 12. 10 | sold outside pharmacies (16-09-2007);~- 2 campaigns
176 IV, 12. 10 | Parliament and of the Council of 16 February 1998 concerning
177 IV, 12. 10 | Half of these policy areas, 16 of them, are more important
178 IV, 12. 10 | domains 1-5.~ ~Most of these 16 policy areas are also linked
179 IV, 12. 10 | obese young people aged 16-24 in the population~ ~Proportion
180 IV, 12. 10 | compulsory school grade 9 (15-16 years) and final grade from
181 IV, 12. 10 | Condom use among young people 16-24 years~A: used a condom
182 IV, 12. 10 | obese young people aged 16-24 in the population~ ~Proportion
183 IV, 13. 3 | population overall, some 16% of EU citizens, i.e. 78
184 IV, 13. 3 | population overall, some 16% of EU citizens, i.e. 78
185 IV, 13. 6. 2 | Charter of Leiden. So far, 16 European countries have
|
|
| |
